Dark Forest Capital Management’s Sage Therapeutics SAGE Stock Holding History

Dark Forest Capital Management’s Portfolio SAGE Stock Details SAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-22,245	Closed	-$242K	–	1125
2024 Q2	$242K	Buy	+22,245	New	+$285K	0.04%	510
2023 Q3	–	Sell	-12,936	Closed	-$608K	–	1288
2023 Q2	$608K	Buy	12,936 +9,754	+307%	+$485K	0.06%	547
2023 Q1	$134K	Buy	+3,182	New	+$137K	0.03%	563
2022 Q4	–	Sell	-21	Closed	-$1K	–	1443
2022 Q3	$1K	Buy	21 +18	+600%	+$696	﹤0.01%	1067
2022 Q2	$0	Buy	+3	New	+$101	﹤0.01%	1314
2022 Q1	–	Sell	-1	Closed	–	–	1698
2021 Q4	$0	Sell	1 -73	-99%	-$3.06K	﹤0.01%	1730
2021 Q3	$3K	Sell	74 -184	-71%	-$8.44K	﹤0.01%	1151
2021 Q2	$15K	Buy	+258	New	+$18.2K	0.01%	595

Other funds holding SAGE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Dark Forest Capital Management's SAGE Position: Q3 2024 in Review

Dark Forest Capital Management sold out of Sage Therapeutics (SAGE) in Q3 2024, closing a stake of 22,245 shares — an estimated $242K sold.

Dark Forest Capital Management first reported a position in SAGE in Q2 2021 and held it in 8 quarters. The position peaked at $608K in Q2 2023. 176 funds tracked by Wall St. Rank hold SAGE as of Q3 2024.

Dark Forest Capital Management reported no remaining Sage Therapeutics position as of Q3 2024 after selling out during the quarter.
Dark Forest Capital Management sold 22,245 Sage Therapeutics shares in Q3 2024, an estimated $242K.
Dark Forest Capital Management first reported a position in Sage Therapeutics in Q2 2021 and held it in 8 quarters.
Dark Forest Capital Management's Sage Therapeutics position peaked at $608K in Q2 2023.
176 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2024.

Based on Dark Forest Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.